You are here: Industry Insights > COVID-19

News List

Celltrion gets priority review in Canada for Covid-19 drug regdanvimab pharmaceutical-technology
August 03, 2021
Health Canada has granted priority review to Celltrion Healthcare’s experimental monoclonal antibody, regdanvimab (CT-P59), for the treatment of Covid-19.
India and UK to conduct clinical trials of Ashwagandha for promoting COVID-19 recovery expresspharma
August 03, 2021
MoU signed between All India Institute of Ayurveda (under the Ministry of Ayush) and the UK’s London School of Hygiene and Tropical Medicine.
AHA News: Dangers of Life-Threatening Second Heart Attack May Be Highest Soon After the First drugs
August 03, 2021
A first heart attack is a serious, life-changing event, although most people now survive them. But a new study underscores the importance of doing everything possible to avoid another one.
After Nearly 9 Million Pfizer Shots for U.S. Teens, Serious Side Effects Rare: CDC drugs
August 03, 2021
U.S. health officials have some reassuring news about the safety of the COVID-19 vaccine in young people: Among millions of U.S. teens who've received Pfizer's shots, serious side effects have been rare.
Troubling Rise Seen in Both COVID-19, RSV Cases Among Children drugs
August 03, 2021
A rise in cases of respiratory syncytial virus (RSV) is unfolding just as COVID-19 infections are increasing among children.
Florida Sees Record Number of COVID-19 Cases, Hospitalizations drugs
August 03, 2021
Florida reached another grim milestone on Sunday when it broke a previous record for COVID-19 hospitalizations that was set before vaccines were available.
New Data Show the Power of COVID-19 Vaccines drugs
August 03, 2021
The effectiveness of COVID-19 vaccines is borne out in new government data showing that more than 99.99 percent of fully vaccinated Americans have not had a breakthrough infection resulting in hospitalization or death.
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19 firstwordpharma
August 03, 2021
Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.
Camostat cuts recovery time in half for mild COVID-19 patients europeanpharmaceuticalreview
August 02, 2021
Phase II trial results suggest Daewoong Pharmaceutical’s Foistar (Camostat mesilate) may significantly expedite recovery from mild COVID-19 symptoms.
Thinking impaired in 60% of COVID-19 survivors worldpharmanews
August 02, 2021
In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page